The document discusses pulmonary embolism (PE), which occurs when blood clots form in the veins (deep vein thrombosis or DVT) and travel to the lungs. Risk factors for PE include inherited factors like Factor V Leiden mutation that cause hypercoagulability, as well as acquired risks like older age, surgery, cancer, and oral contraceptives. PE can cause hypoxemia and other symptoms by obstructing blood flow and damaging the ventilation-perfusion ratio in the lungs. The document outlines inherited and acquired causes of hypercoagulability that predispose individuals to DVT and PE.
3. 1.
2.
3.
Where do 95% of pulmonary
thromboemboli originate?
What are the risk factors for pulmonary
thromboemboli?
What hemodynamic changes are brought
about by significant pulmonary
thromboemboli?
www.medicinemcq.com
3
4. 4.
5.
6.
What changes in ventilation/perfusion
relationships are brought about by
significant pulmonary thromboemboli?
What are the causes of hypoxemia in
pulmonary thromboembolism.
What are the clinical manifestations of
pulmonary thromboembolism?
www.medicinemcq.com
4
5. Includes
• Pulmonary embolism (PE)
• Deep venous thrombosis (DVT)
www.medicinemcq.com
5
14. Synthesized
by the liver
Converted to an active protease by
thrombin
• Protein C becomes an anticoagulant when it is
activated by thrombin.
www.medicinemcq.com
14
15. Protein
produced by endothelial cells
• Enhances thrombin activation of protein C
www.medicinemcq.com
15
19. Proteins
C and S
• Reduced blood levels
• Dysfunctional
•
www.medicinemcq.com
19
20. Makes
factor V resistant to protein C
inhibition
Hypercoagulable state
Many patients with venous
thromboembolism have this defect
For rest of the slides visit
Respiratory system
www.medicinemcq.com >
www.medicinemcq.com
20